Thank you.
We'll turn now to Mr. Daley.
Mr. Daley, we heard from a witness earlier this week about some of the flexibilities that are already included in the TRIPS agreement. He cited three different articles in the TRIPS agreement that provided flexibilities that would help developing countries access vaccines, and he encouraged all countries to be using those flexibilities.
What is your opinion on the existing mechanisms available under the TRIPS agreement, and do you think that they can be used successfully?